Summit Therapeutics Stock Climbs After CEO Buy
Summit Therapeutics shares saw a notable uptick following a recent regulatory filing revealing that the company’s CEO has increased their personal stake. Investor sentiment bolstered on the news, as executive insider buying is frequently interpreted as a vote of confidence in the firm’s clinical pipeline and long-term financial health.